NR4A1 and diabetic kidney disease: BA, a triterpenoid with established efficacy in oncology and viral infections.12,13 Although BA has been reported to exert an anti-inflammatory effect in diabetic nephropathy, our findings confirmed that BA emerges as a groundbreaking therapeutic candidate for MsPGN through NR4A1.